Internal link ProQR Announces Encouraging AX-0810 Phase 1 Safety and PK Data, Development Candidate Selections, and 2026 Outlook January 08, 2026 at 01:00 PM UTC
Internal link ProQR Therapeutics Announces Results for the Third Quarter of 2014 November 24, 2014 at 12:00 PM UTC
Internal link ProQR Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares September 23, 2014 at 05:37 PM UTC